Acrivon Therapeutics Appoints Adam Levy, Ph.D., M.B.A. as Chief Financial Officer
Position
Chief Financial Officer
Company
Acrivon Therapeutics
WatertownBiotechnologyHealth CareMedicalTherapeuticsBiopharmaDescription
Acrivon Therapeutics announced the appointment of Adam Levy, Ph.D., M.B.A., as Chief Financial Officer effective April 1, 2025. Dr. Levy brings over 25 years of experience in finance and investor relations within the biopharma sector.
Quick answer
Acrivon Therapeutics Appoints Adam Levy, Ph.D., M.B.A. as Chief Financial Officer (March 14, 2025). Acrivon Therapeutics is based in Watertown, Massachusetts, United States.
- Who is the new Chief Financial Officer at Acrivon Therapeutics?
- Acrivon Therapeutics named Adam Levy Chief Financial Officer, announced March 14, 2025.
- What did Acrivon Therapeutics announce on March 14, 2025?
- Acrivon Therapeutics announced the appointment of Adam Levy, Ph.D., M.B.A., as Chief Financial Officer effective April 1, 2025. Dr. Levy brings over 25 years of experience in finance and investor relations within the biopharma sector.
- What does Acrivon Therapeutics do?
- Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.
- Where is Acrivon Therapeutics based?
- Acrivon Therapeutics is based in Watertown, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (March 20, 2025), Hansa Biopharma (April 24, 2025), Life Seal Vascular (March 13, 2025) and Immuneering (March 20, 2025) also announced leadership changes within 45 days of Acrivon Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia and Gulf Countries (March 20, 2025)
- Hansa Biopharma Appoints Renée Aguiar-Lucander as Chief Executive Officer (April 24, 2025)
- Life Seal Vascular Appoints Matt Thompson as Chief Executive Officer (CEO) (March 13, 2025)
- Igor Matushansky, MD, PhD, Joins Immuneering as Chief Medical Officer (March 20, 2025)
- Nanoscope Therapeutics Appoints Ademola Daramola as Vice President, Quality and Compliance (March 20, 2025)
- Byondis Appoints Christoph Korpus as Chief Business Officer (CBO) (March 25, 2025)
Who to call at Acrivon Therapeutics, and when
A new leader at Acrivon Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Acrivon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Acrivon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Acrivon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Acrivon Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Acrivon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.